levothyroxine sodium
- Product NDC
- 50090-4799
- 11-digit product format
- 500904799
- Labeler code
- 50090
- Product ID
- 50090-4799_f2ee3fc5-4e2b-4b13-bd7c-7cbbf520ac1f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levothyroxine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA021116
- Marketing category
- NDA
- Marketing start
- 2019-05-07
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 125 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- levothyroxine sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | 125 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 966224 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-4799-0 | levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | | 11 |
| 50090-4799-1 | levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | | 11 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-4799-0 | 50090479900 | 30 TABLET in 1 BOTTLE (50090-4799-0) | 30 tablet | 2019-12-16 | 0000-00-00 | No | No | Current |
| 50090-4799-1 | 50090479901 | 90 TABLET in 1 BOTTLE (50090-4799-1) | 90 tablet | 2019-12-16 | 0000-00-00 | No | No | Current |